Is India’s diagnostics sector poised for a long-term growth upswing? Axis Securities sees opportunity in three stocks
60-Word AI Digest
Axis Securities sees India’s diagnostics sector entering a multi-year growth upcycle, supported by rising demand, scalable models and strong cash generation. It initiated BUY coverage on Dr. Lal PathLabs, Vijaya Diagnostic Centre and Nephrocare Health Services.
Key Takeaways
- Axis Securities sees India’s diagnostics sector entering a multi-year growth upcycle, supported by rising demand, scalable models and strong cash generation.
- It initiated BUY coverage on Dr.
- Lal PathLabs, Vijaya Diagnostic Centre and Nephrocare Health Services.
Axis Securities sees India’s diagnostics sector entering a multi-year growth upcycle, supported by rising demand, scalable models and strong cash generation. It initiated BUY coverage on Dr. Lal PathLabs, Vijaya Diagnostic Centre and Nephrocare Health Services.
Original Publisher Attribution
This summary was curated from Livemint.